EVGN Evogene Ltd.
$0.36▼ -1.68%
Healthcare
Other
Volume 9.7K
Avg Volume (10D) 43.1K
Key Metrics & Fundamentals
Market Cap
$4.94M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.35 - 1.33
% vs 50 MA
-21.14%
% vs 200 MA
-46.02%
RSI-14
38.4
MACD Histogram
+0.0000
Beta (1Y vs SPY)
1.38
Free Cash Flow
-$1.98M
Gross Rev
$347,000
Gross Profit
$141,000
EBITDA
-$1.27M
COGS
$206,000
Operating Exp
$2.70M
Operating Income
-$2.56M
EBIT
-$2.56M
Pretax Income
-$1.59M
Net Income
-$1.77M
EPS (Diluted)
-0.14
Price & Volume History
Loading chart…
Recent News
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
PR Newswire · Oct 26, 2026 8:00 AM ET
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
PR Newswire · Oct 20, 2026 8:00 AM ET
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
PR Newswire · Oct 6, 2026 4:00 PM ET
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
PR Newswire · Sep 30, 2026 7:15 AM ET
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
PR Newswire · Aug 31, 2026 8:00 AM ET
EverGen Infrastructure Reports Q2 2026 Results
Business Wire · Aug 27, 2026 12:26 AM ET
EverGen Infrastructure Announces Voting Results for the Annual General Meeting of Shareholders Held on August 25, 2026
Business Wire · Aug 26, 2026 5:00 PM ET
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 25, 2026 7:45 AM ET
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Evogene Ltd. Shareholders Vote "FOR" the Company's Slate of Highly Qualified Director Nominees
PR Newswire · Aug 25, 2026 7:00 AM ET
Evogene Ltd. Q2 2026 Earnings Call Summary
Moby · Aug 19, 2026 8:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See EVGN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.